Skip to content

Every1Mobile: Digital Health in International Development

Calculus Capital portfolio company Every1Mobile’s Head of Programme Design, Abi Gleek recently spoke at a DAI panel discussion on “Digital Health in International Development: Current Realities and Future Trends” in London. Abi shared insights from the U Afya programme in Nairobi, Kenya where Every1Mobile is working with mothers and mothers-to-be in informal settlements, to design a … Continued

Calculus invests £2m in CloudTrade

CloudTrade’s technology – which has been patented in Europe, the US and Australia – enables companies to automatically process electronic documents such as invoices and sales orders received by email. The software extracts information from a human-readable, machine-generated document, such as a PDF, validates it and then converts it into a data file that is … Continued

EISA launches new free membership programme for Financial Planners & Regulated Advisers

The Enterprise Investment Scheme Association (EISA) has launched a new membership programme specifically aimed at Financial Planners and Regulated Advisers. And its FREE! Called the Financial Planning Programme, EISA aims to provide all individuals in the financial planning community with a forum for both representing your views and keeping you up to date with industry issues. … Continued

Axol Bioscience introduces Human iPSC-derived Atrial Cardiomyocytes

Calculus Capital portfolio company, Axol Bioscience Ltd., has launched their Human iPSC-derived Atrial Cardiomyocytes for the discovery and development of novel treatments and advancing our understanding of cardiovascular disease. As a human cell culture specialist they already provide custom services for disease modelling and drug discovery markets.  Generated from the same donor as Axol’s highly validated … Continued

Scancell announces in-licence drug delivery technology deal with Ichor Medical Systems

Scancell announced today that it has exercised its option to a worldwide commercial licence for the use of Ichor Medical Systems proprietary TriGrid® 2.0 electroporation delivery system with SCIB1, Scancell’s ImmunoBody® vaccine for the treatment of advanced melanoma. The new technology will be used in an upcoming cancer trial, specifically deployed in an upcoming phase … Continued

John Glencross chairs BIA discussion ‘How to fund your biotech breakthrough’

The Bioindustry Association held an informative webinar chaired by Calculus Capital Chief Executive John Glencross with panellists Michael Kipping-  Innovation Lead at Innovate UK, Oliver Sexton- Investment Director at UK Innovation & Science Seed Fund and Kaivan Faria- Investment Analyst at Newable, on the topic ‘How to fund your biotech breakthrough.’ To listen to the webinar click here

Collagen Solutions emerges from ‘challenging’ year in stronger position

Collagen Solutions PLC (LON:COS) CEO Jamal Rushdy and CFO Hilary Spence discuss with Proactive Investors the firm’s results for the year ended 31 March 2018.  During the interview with Andrew Scott they discuss recent results, exciting projects and opportunities for the business. The company recently featured in a Calculus “Spotlight On” article containing further information about how the … Continued